26 ORAL Phase Ib and pharmacodynamic study of the MEK inhibitor AZD6244 (ARRY-142886) in patients with advanced solid malignancies

Autor:	L. Maloney, S. Brown, R.B. Cohen, C. Morris, A. Adjei, J. Molina, E. Temmer, S. Hariharan, S. G. Eckhardt, Wilbur A. Franklin
Rok vydání:	2006
Předmět:	Cancer Research Pharmacodynamic Study Oncology business.industry MEK Inhibitor AZD6244 Medicine In patient Pharmacology business
Zdroj:	European Journal of Cancer Supplements. 4:12
ISSN:	1359-6349
DOI:	10.1016/s1359-6349(06)70031-3
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::91ffcbd1fc0ba59e98cd4459521abe46 https://doi.org/10.1016/s1359-6349(06)70031-3 Zobrazit plný text záznamu Full Text from ScienceDirect